Taiflex Scientific revenue and financials
$304.50Change from previous close: +3.05%Absolute change: +$9.00
In the fiscal year ended December 2025, Taiflex Scientific reported revenue of $10.61B (+6.75% year over year). Net income was $535.12M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +6.75%
- 2025 vs 2024
- Net income growth
- −9.73%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 6.0%
Financial data
Amounts in millions of TWD; per-share values in TWD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total revenue | 2,696 | 2,415 | 2,745 | 2,762 | 2,227 |
| Cost of revenue | 2,073 | 1,883 | 2,208 | 2,208 | 1,810 |
| Gross profit | 624 | 532 | 537 | 554 | 417 |
| Selling, general and administrative | 292 | 261 | 294 | 259 | 232 |
| Research and development | 161 | 130 | 159 | 95.7 | 90.4 |
| Operating income | 171 | 142 | 84.2 | 199 | 94.5 |
| EBIT | 318 | 226 | 246 | 35.7 | 111 |
| EBITDA | 468 | 374 | 386 | 169 | 247 |
| Interest expense | 7.7 | 6.3 | 5.6 | 5.5 | 5.9 |
| Pre-tax income | 311 | 220 | 240 | 30.1 | 105 |
| Income tax | 69.1 | 44.9 | 47.9 | 7.0 | 20.4 |
| Net income | 240 | 171 | 193 | 32.7 | 82.5 |
| Net income to common shareholders | 240 | 171 | 193 | 32.7 | 82.5 |
| Basic EPS | 0.91 | 0.65 | — | 0.13 | 0.32 |
| Diluted EPS | 0.91 | 0.65 | — | 0.13 | 0.31 |
| Average shares (basic) | 264 | 263 | — | 252 | 256 |
| Average shares (diluted) | 264 | 264 | — | 252 | 264 |